SRx Health Solutions Inc. (SRXH)
NYSEAMERICAN: SRXH · Real-Time Price · USD
0.2472
-0.0147 (-5.61%)
At close: Nov 20, 2025, 4:00 PM EST
0.2469
-0.0003 (-0.12%)
Pre-market: Nov 21, 2025, 4:45 AM EST

SRx Health Solutions Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Sep '24 Sep '23 Sep '22
70.97148.42119.4293.18
Revenue Growth (YoY)
-24.28%28.16%-
Cost of Revenue
59.47123.5595.7279.8
Gross Profit
11.524.8723.7113.39
Selling, General & Admin
45.2540.7830.8113.22
Operating Expenses
48.2443.832.5514.56
Operating Income
-36.74-18.93-8.85-1.17
Interest Expense
-4.07-4.02-1.83-0.76
Earnings From Equity Investments
----0.18
Other Non Operating Income (Expenses)
-1.18-0.46-0.130.09
EBT Excluding Unusual Items
-41.99-23.41-10.81-2.02
Merger & Restructuring Charges
-3.3--0.18-
Impairment of Goodwill
-19.73-19.92--
Asset Writedown
-4.26-1.58--
Pretax Income
-63.34-44.91-10.99-2.02
Income Tax Expense
-1.09-0.920.20.44
Net Income
-62.25-43.99-11.18-2.46
Net Income to Common
-62.25-43.99-11.18-2.46
Shares Outstanding (Basic)
1113121
Shares Outstanding (Diluted)
1113121
Shares Change (YoY)
-1.38%1659.27%-
EPS (Basic)
-5.90-3.50-0.90-3.50
EPS (Diluted)
-5.90-3.50-0.90-3.50
Free Cash Flow
-15.65-1.721.583.15
Free Cash Flow Per Share
-1.48-0.140.134.48
Gross Margin
16.20%16.75%19.85%14.36%
Operating Margin
-51.76%-12.75%-7.41%-1.26%
Profit Margin
-87.70%-29.64%-9.36%-2.64%
Free Cash Flow Margin
-22.05%-1.16%1.32%3.38%
EBITDA
-33.19-16.86-7.07-0.54
EBITDA Margin
-46.76%-11.36%-5.92%-0.58%
D&A For EBITDA
3.552.071.770.63
EBIT
-36.74-18.93-8.85-1.17
EBIT Margin
-51.76%-12.75%-7.41%-1.26%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q